Table B: GAAP to Non-GAAP reconciling items (Three Months Ended Q4 2016)

Cost of
revenues

Research
and
development

SG&A

Amortization of
Intangible
assets

Impairment
related to
assets held for
sale

Interest
and other
expense,
net

Income
tax
provision

GAAP [i]

$

328,220

$

92,188

$

94,076

$

52,104

$

1,960

$

(33,155)

$

(790)

[1] Stock based compensation, including costs related to modification of equity awards

6,589

16,687

12,292

—

—

—

—

[2] Changes in value of deferred compensation plan

42

147

292

—

—

(641)

—

[3] Merger, integration and related costs

2,614

476

5,136

—

—

—

—

[4] Inventory Step-up related to acquisition accounting

1,381

—

—

—

—

—

—

[5] Losses from equity method investments

—

—

—

—

—

8,766

—

[6] Imputed interest on convertible debt, equity component amortization on convertible debt and others

—

—

—

—

—

3,482

—

[7] Amortization of debt issuance costs

—

—

—

—

—

976

—

[8] Amortization of  Intangible assets

—

—

—

52,104

—

—

—

[9] Impairment related to assets held for sale

—

—

—

—

1,960

—

—

[10] Restructuring costs, including executive severance

—

—

17,237

—

—

—

—

[11] Tax impact of Non-GAAP adjustments

—

—

—

—

—

(908)

(2,442)

Non - GAAP [ii]

$

317,594

$

74,878

$

59,119

$

—

$

—

$

(21,480)

$

(3,232)

Impact of reconciling items [ii - i]

$

(10,626)

$

(17,310)

$

(34,957)

$

(52,104)

$

(1,960)

$

11,675

$

(2,442)